Stay updated on Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.

Latest updates to the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoChange DetectedThe updates are minor UI/text changes (e.g., showing the glossary, new/updated footer items like 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'), along with capitalization adjustments. They do not modify study details, eligibility, or trial data.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, reflecting a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a Locations section highlighting Colorado as a study site; removed the old Colorado Locations entry and the HHS Vulnerability Disclosure, and updated the site revision to v3.3.3.SummaryDifference0.2%

- Check54 days agoChange DetectedResults-related updates were added to the study page, including a posting on 2025-12-12 and milestones for outcomes such as Endobronchial Histology and irAEs, plus links to the protocol document and revised enrollment/completion dates.SummaryDifference2%

- Check75 days agoChange DetectedRevision: v3.3.2 added; previous revision v3.2.0 removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.